Brain Cannabinoid CB2 Receptor in Schizophrenia - Ishiguro, Hiroki; Horiuchi, Yasue; Ishikawa, Maya; Koga, Minori; Imai, Keiko; Suzuki, Yoshimi; Morikawa, Miyuki; Inada, Toshiya; Watanabe, Yuichiro; Takahashi, Makoto; Someya, Toshiyuki; Ujike, Hiroshi; et al. (Biological psychiatry (1969), 2010)
Keywords: Adult and adolescent clinical studies; Animals; Association; Biological and medical sciences; Brain - metabolism; cAMP; cannabinoid; Case-Control Studies; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP - metabolism; G protein coupled receptor; gene; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Indoles - pharmacology; Medical sciences; methamphetamine; Mice; Mice, Inbred C57BL; MK-801; Motor Activity - drug effects; mouse; Neuropharmacology; Pharmacology. Drug treatments; Polymorphism, Single Nucleotide; postmortem brain; Psychiatry; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease); Psychology. Psychoanalysis. Psychiatry; Psychopathology. Psychiatry; Psychopharmacology; Psychoses; Receptor, Cannabinoid, CB2 - antagonists & inhibitors; Receptor, Cannabinoid, CB2 - genetics; Receptor, Cannabinoid, CB2 - metabolism; Reflex, Startle - drug effects; Schizophrenia; Schizophrenia - genetics; Schizophrenia - metabolism; MK-801; mouse; Association; G protein coupled receptor; gene; methamphetamine; cannabinoid; postmortem brain; schizophrenia; cAMP; Amphetamine derivatives; Psychotropic; Central nervous system; Metamfetamine; Schizophrenia; Glutamate receptor; Cannabinoid; Genetic determinism; Encephalon; Psychosis; Gene; Cannabinoid receptor; Genetics; Drug of abuse; Antagonist; G protein; Biological receptor; CNS stimulant; Dizocilpine; Rodentia; Postmortem; Cyclic AMP; Neuroprotective agent; CB2 cannabinoid receptor; Sympathomimetic; Vertebrata; Mammalia; Mouse; Animal; NMDA receptor